Biotechnology (67) | Security Agreements (67)

Browse by Company

Recent Contracts

Security Agreement, dated as of May 24, 2022, by and among Halozyme Therapeutics, Inc., the Guarantors and Bank of America N.A (HALOZYME THERAPEUTICS INC, Filed With SEC on May 24, 2022)
Security Agreement, dated May 17, 2022, by Clene Nanomedicine, Inc. in favor of the Department of Housing of Community Development, a principal department of the State of Maryland (Chelsea Worldwide Inc., Filed With SEC on May 19, 2022)
Security Agreement between Cellvera Holdings and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
Security Agreement between Cellvera Development LLC and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
Security Agreement between Cellvera Global Holdings LLC and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
Amended and Restated Security Agreement between Cellvera Asia Limited and Aditxt, Inc. dated as of March 31, 2022 (ADiTx Therapeutics, Inc., Filed With SEC on May 16, 2022)
Form of Security Agreement dated May 11, 2022 (Adhera Therapeutics, Inc., Filed With SEC on May 16, 2022)
Security Agreement dated as of April 10, 2022 by Navidea Biopharmaceuticals, Inc. in favor of John Kim Scott, Jr (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on April 12, 2022)
Security Agreement, dated as of March 23, 2022, by and among the Company, certain subsidiaries of the Company and Hayfin Services LLP (ADMA BIOLOGICS, INC., Filed With SEC on March 24, 2022)
Security Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited (AgeX Therapeutics, Inc., Filed With SEC on February 15, 2022)